Table 1.
Donor and recipient characteristics as well as transplant related-variables from the studied cohort.
| Variable | n = 85 |
|---|---|
| Donor type (SCD/ECD/LD) | 42 (49.4%)/30 (35.3%)/13 (15.3%) |
| Donor age (years) | 52 ± 15 |
| Donor gender (m/f) | 50 (58.8%)/35 (41.2%) |
| Recipient age (years) | 53 ± 13 |
| Recipient gender (m/f) | 66 (77.6%)/19 (22.4%) |
| First transplant/re-transplant | 76 (89.4%)/9 (10.6%) |
| Primary renal disease (GN/ADPKD/diabetes/others/unknown) | 21 (24.7%)/22 (25.9%)/8 (9.4%)/12 (14.1%)/22 (25.9%) |
| Class I HLA mismatch (A + B) | 2.6 ± 0.9 |
| Class II HLA mismatch (DR) | 0.9 ± 0.7 |
| Induction (Basiliximab/ATG) | 52 (61.2%)/33 (38.8%) |
| DGF (no/yes) | 80 (94%)/5 (6.0%) |
| T cell-mediated rejection (no/yes) | 81 (95.3%)/4 (4.7%) |
| CMV infection (no/viremia/disease) | 71 (83.5%)/10 (11.8%)/4 (4.7%) |
| Polyoma BK virus infection (no/viremia/nephropathy) | 79 (92.9%)/6 (7.1%)/0 (0%) |
| Post-transplant diabetes mellitus (no/yes) | 61 (79.2%)/16 (20.8%) |
SCD, standard criteria deceased donor; ECD, expanded criteria deceased donor; LD, living donor; GN, glomerulonephritis; ADPKD, autosomal dominant polycystic kidney disease; DGF, delayed graft function; CMV, cytomegalovirus.